These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2185995)

  • 1. Detection of antibodies to human T-lymphotropic virus type I by using synthetic peptides.
    Kuroda N; Washitani Y; Shiraki H; Kiyokawa H; Ohno M; Sato H; Maeda Y
    Int J Cancer; 1990 May; 45(5):865-8. PubMed ID: 2185995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological discrimination between HTLV-I and HTLV-II antibodies by ELISA using synthetic peptides as antigens.
    Washitani Y; Kuroda N; Shiraki H; Nishimura Y; Yamaguchi K; Takatsuki K; Fernando LP; Fang CT; Kiyokawa H; Maeda Y
    Int J Cancer; 1991 Sep; 49(2):173-7. PubMed ID: 1879964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.
    Washitani Y; Kuroda N; Shiraki H; Itoyama Y; Sato H; Ohshima K; Kiyokawa H; Maeda Y
    J Clin Microbiol; 1992 Feb; 30(2):287-90. PubMed ID: 1537894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serologic discrimination of human T cell lymphotropic virus infection by using a synthetic peptide-based enzyme immunoassay.
    Lal RB; Rudolph DL; Lairmore MD; Khabbaz RF; Garfield M; Coligan JE; Folks TM
    J Infect Dis; 1991 Jan; 163(1):41-6. PubMed ID: 1984475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure to detect evidence of human T-lymphotropic virus (HTLV) type I and type II in blood donors with isolated gag antibodies to HTLV-I/II.
    Lal RB; Rudolph DL; Coligan JE; Brodine SK; Roberts CR
    Blood; 1992 Jul; 80(2):544-50. PubMed ID: 1627806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type- and group-specific continuous antigenic determinants of HTLV. Use of synthetic peptides for serotyping of HTLV-I and -II infection.
    Blomberg J; Robert-Guroff M; Blattner WA; Pipkorn R
    J Acquir Immune Defic Syndr (1988); 1992; 5(3):294-302. PubMed ID: 1371319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.
    Desgranges C; Souche S; Vernant JC; Smadja D; Vahlne A; Horal P
    AIDS Res Hum Retroviruses; 1994 Feb; 10(2):163-73. PubMed ID: 8198868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of immunodominant epitopes of gag and pol gene-encoded proteins of human T-cell lymphotropic virus type I.
    Lal RB; Rudolph DL; Griffis KP; Kitamura K; Honda M; Coligan JE; Folks TM
    J Virol; 1991 Apr; 65(4):1870-6. PubMed ID: 2002547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme immunoassay with synthetic peptides to detect anti-HTLV-I antibodies.
    Yamada K; Kuroda N; Washitani Y; Shiraki H; Maeda Y
    Clin Chem; 1992 May; 38(5):699-703. PubMed ID: 1582023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Evaluation of a Novel ELISA for Detection of Antibodies against HTLV-I Using Chimeric Peptides.
    Mosadeghi P; Heydari-Zarnagh H
    Iran J Allergy Asthma Immunol; 2018 Apr; 17(2):144-150. PubMed ID: 29757587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serological evaluation of human T lymphotropic virus type-I infection in routine hospital samples, especially using serodia.HTLV-I].
    Kamihira S; Nakashima S; Fukahori Y; Toriya K; Kanamura M; Ohta T
    Rinsho Byori; 1990 Jul; 38(7):783-8. PubMed ID: 2205742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutralizing activity of human antibodies against the structural protein of human T-cell lymphotropic virus type I.
    Inoue Y; Kuroda N; Shiraki H; Sato H; Maeda Y
    Int J Cancer; 1992 Dec; 52(6):877-80. PubMed ID: 1459728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Identification of immunoreactive epitopes in proteins coded by gag, env, and pol genes of the type I human T-lymphotropic virus (HTLV-I) using synthetic peptides].
    Iaroslavtseva NG; Ivanov VS; Grebennikova ZhO; Kornilaeva GV; Pashkova TA; Chikin LD; Ostrovskiĭ AG; Andreev SM; Khaitov RM; Karamov EV
    Bioorg Khim; 1995 Oct; 21(10):752-60. PubMed ID: 8573207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.
    Palker TJ; Tanner ME; Scearce RM; Streilein RD; Clark ME; Haynes BF
    J Immunol; 1989 Feb; 142(3):971-8. PubMed ID: 2563272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chimeric synthetic peptides containing two immunodominant epitopes from the envelope gp46 and the transmembrane gp21 glycoproteins of HTLV-I virus.
    Hernández Marin M; Castellanos Pentón P; Márquez Bocalandro Y; Pozo Peña L; Díaz Navarro J; González López LJ
    Biochem Biophys Res Commun; 2001 Nov; 289(1):1-6. PubMed ID: 11708767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunoreactivity of synthetic peptides, corresponding to B-cellular epitopes of human type I T-lymphotrophic virus structural proteins].
    Rasuli AM; Klepikov NN; Andreev SM; Sidorova MV; Vafina MG; Seniuta NB; Pavlish OA; Syrtsev AV; Gurtsevich VE
    Mol Biol (Mosk); 1993; 27(4):880-7. PubMed ID: 8361494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An enzyme-linked immunosorbent assay for immune complex of HTLV-I.
    Ishibashi K; Hanada S; Uozumi K; Otsuka M; Sakurami T; Hashimoto S
    J Immunol Methods; 1989 May; 119(2):217-21. PubMed ID: 2786036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of antibodies to trans-activator protein (p40taxI) of human T-cell lymphotropic virus type I by a synthetic peptide-based assay.
    Rudolph DL; Coligan JE; Lal RB
    Clin Diagn Lab Immunol; 1994 Mar; 1(2):176-81. PubMed ID: 7496941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of immunoreactive synthetic HTLV-1 peptides in the search for antibody reactivity in multiple sclerosis.
    Lycke J; Andersen O; Svennerholm B; Ben-Menachem E; Horal P; Vahlne A
    Acta Neurol Scand; 1992 Jan; 85(1):44-54. PubMed ID: 1546533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of new epitopes recognized by human monoclonal antibodies with neutralizing and antibody-dependent cellular cytotoxicity activities specific for human T cell leukemia virus type 1.
    Kuroki M; Nakamura M; Itoyama Y; Tanaka Y; Shiraki H; Baba E; Esaki T; Tatsumoto T; Nagafuchi S; Nakano S
    J Immunol; 1992 Aug; 149(3):940-8. PubMed ID: 1378869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.